BZ NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Kanzhun Ltd ADR · Communication Services · Internet Content & Information

Open interactive chart View report data Download investor PDF
Latest close 15.42 USD
3.4% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 1.2% above the Trend Line and sits at 22.8% of its 52-week range. The latest completed week returned 3.4%, after a 16.0% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers. Options positioning is volatility with 51/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal; earnings are due in 20d.

Setup score 36 out of 100
Latest Close 15.42 USD 24 Jul 2026
1W Return 3.4% latest completed week
4W Return 16.0% short-term follow-through
12W Return 13.0% quarterly tape
Trend Breadth 42.3% 22 of 52 weeks active
Volume Ratio 0.8x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 3.4% Latest completed week; four-week move 16.0%. Indicator stack 23/64 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 51/100 conviction; expected move 12.5%. News sentiment 57/100 41 relevant articles in the latest sentiment read. Event risk 20d Next report is scheduled for 19 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 1.2% above the Trend Line and sits at 22.8% of its 52-week range. The latest completed week returned 3.4%, after a 16.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0612-week average 0.04

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals2Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 16.0% over four weeks, 13.0% over 12 weeks, and -22.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W3.4%
4W16.0%
12W13.0%
26W-19.9%
52W-22.6%
Active trend streak0 weeks
Active weeks in one year22
Trend breadth42.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.58Latest activity-pressure read.
Pressure change38.4%Four-week change in activity pressure.
Leadership-22.65Latest relative-leadership reading.
RS change39.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength91/100Blend of value, momentum, and quality. Underlying universe rank 10; rank 1 is best.
Value99/100Relative valuation strength. Underlying universe rank 2; rank 1 is best.
Quality97/100Profitability and accounting quality. Underlying universe rank 4; rank 1 is best.
Momentum13/100Medium-term price momentum. Underlying universe rank 88; rank 1 is best.
Growth89/100Revenue and earnings growth. Underlying universe rank 12; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
2.0x
Price divided by trailing earnings.
Price / sales
0.8x
Market value relative to trailing revenue.
EV / EBITDA
0.7x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
134.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
85.5%
Gross profit retained from each unit of revenue.
Operating margin
33.5%
Operating profit retained from revenue.
Free-cash-flow margin
59.7%
Free cash flow generated from revenue.
Return on invested capital
13.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
10.9%
Latest one-year revenue growth.
EPS growth
82.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
25.3%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.1%
Cash dividends relative to market value.
Buyback yield
-27.0%
Net share repurchases relative to market value.
Shareholder yield
-25.9%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

BZ shows volatility options pressure with a 51/100 conviction score, put-call volume ratio of 0.00, expected move of 12.5%, and Sharemaestro trend signal inactive.

Conviction51/100
Expected move12.5%
Put/call volume0.00
Pressure100
Speculation5
Volatility75
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment57/100

Weighted news tone is neutral across 41 relevant articles.

17 positive · 21 neutral · 3 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings20dNext report is scheduled for 19 Aug 2026; event risk rises as the date approaches.
Options expected move12.5%Nearest-chain priced movement where available.
52-week drawdown-38.5%Distance below the 52-week high.
13-week volatility3.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2615 weeks finished lower.
Best week+8.9%Week of 17 Apr.
Worst week-8.0%Week of 27 Feb.
Latest week+3.4%Week of 24 Jul.

Shape of recent returns

Strong gains3
Modest gains7
Flat weeks1
Modest losses11
Sharp losses4
Recent vol3.4%13-week weekly-return volatility.
Base vol4.6%52-week weekly-return volatility.
Up/down split23/28Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis23/100

Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.

Activity pressure 0.06; No reversal markers Factors76/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 93; Small Cap Core rank 6 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options35/100

BZ shows volatility options pressure with a 51/100 conviction score, put-call volume ratio of 0.00, expected move of 12.5%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 12.5% Sentiment57/100

Weighted news tone is neutral across 41 relevant articles.

Lazard Asset Management LLC Has $26.80 Million Stock Position in KANZHUN LIMITED Sponsored ADR $BZ Insiders50/100

No recent insider transaction evidence is stored.

 Earnings20d

Next report is scheduled for 19 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202615.42 USD3.4%15.24 USD16.77 USD0.58-22.6513.8MOff
17 Jul 202614.91 USD8.4%15.43 USD16.79 USD0.48-27.0213.2MOff
10 Jul 202613.76 USD5.8%15.63 USD16.79 USD0.39-35.9717.1MOff
3 Jul 202613.00 USD-2.2%15.84 USD16.81 USD0.33-38.9711.1MOff
26 Jun 202613.29 USD-3.0%16.13 USD16.82 USD0.42-37.6320.8MOff
19 Jun 202613.70 USD0.0%16.42 USD16.83 USD0.29-39.1517.9MOff
12 Jun 202613.70 USD-2.4%16.65 USD16.83 USD0.23-38.1216.6MOff
5 Jun 202614.03 USD3.4%16.87 USD16.85 USD0.15-35.7520.5MOff
29 May 202613.57 USD-1.3%17.11 USD16.86 USD-0.09-41.1818.2MOff
22 May 202613.75 USD-2.3%17.40 USD16.86 USD-0.41-39.2024.6MOff
15 May 202614.07 USD0.4%17.68 USD16.87 USD-0.75-37.6020.6MOff
8 May 202614.02 USD2.7%17.93 USD16.88 USD-1.05-38.5817.0MOff
1 May 202613.65 USD0.2%18.18 USD16.90 USD-1.35-37.3915.0MOff
24 Apr 202613.62 USD-4.2%18.51 USD16.93 USD-1.44-37.0623.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.